Beyond pharmaceutical bandaids: universal access to antiretroviral therapy in Canada
Julien Brisson, Nancy Sheehan, Benoit Lemire, Ken Monteith, Pierre-Marie David · 2026
Read Beyond pharmaceutical bandaids: universal access to antiretroviral therapy in Canada by Julien Brisson, Nancy Sheehan, Benoit Lemire, Ken Monteith, Pierre-Marie David (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13585391.txt.
Description
Julien Brisson and co-authors argue that Canada must fund HIV treatment universally instead of leaning on drug company charity, in work from twenty twenty-six. A commentary they answer had demanded free antiretroviral access nationwide. Treatment doubles as prevention once the virus is suppressed. A manufacturer's coming withdrawal of copayment help exposes the fragility. Four common drug combinations lose their assistance lifeline soon.
Coverage already varies wildly between provinces today. Some provinces fund treatment fully through public plans. The two biggest provinces leave many patients facing real costs. Coverage type measurably tracks viral suppression in Ontario data. Private assistance quietly papers over a structural public gap. Universal funding is framed as the only durable fix.
Catalog record
| CREATOR | Julien Brisson, Nancy Sheehan, Benoit Lemire, Ken Monteith, Pierre-Marie David |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |